Stephen A. Wring

Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery

Joseph W. Polli, Stephen A. Wring, Joan E. Humphreys et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 662 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs

Kelly M. Mahar Doan, Joan E. Humphreys, Lindsey O. Webster et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 626 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

Robert T. Jacobs, Bakela Nare, Stephen A. Wring et al. · PLoS neglected tropical diseases · 2011 · 299 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Recent developments in the design and application of screen-printed electrochemical sensors for biomedical, environmental and industrial analyses

John P. Hart, Stephen A. Wring · TrAC Trends in Analytical Chemistry · 1997 · 280 citations

Engineering, Biomedical Engineering, Chemical Engineering +16

Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

John J. Dwyer, Karen L. Wilson, Donna K. Davison et al. · Proceedings of the National Academy of Sciences · 2007 · 240 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17